Summary Of Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2011

Summary Of Significant Accounting Policies

Summary Of Net Revenues By Product Category

	For The Three Months Ended September 30,				For The Nine Months Ended September 30,
	2011		2010		2011		2010
	(In thousands)				(In thousands)
Respiratory and other chronic therapies	$	423,886	$	371,207	$	1,212,928	$	1,111,069
DME, infusion and enteral therapies		50,872		47,466		142,430		136,010
Total	$	474,758	$	418,673	$	1,355,358	$	1,247,079

Schedule Of Operating Expenses By Category

Operating Expenses (in thousands)	For The Three Months Ended September 30,				For The Nine Months Ended September 30,
	2011		2010		2011		2010
Salary and related	$	71,479	$	64,645	$	204,255	$	192,711
Facilities		15,981		15,917		44,412		46,781
Vehicles		14,360		11,938		40,780		35,446
General supplies/miscellaneous		10,272		7,964		26,741		23,726
Total	$	112,092	$	100,464	$	316,188	$	298,664